BRAINLIFE.ORG





Topics


Glioblastoma | Treatment | Targeted therapy | Bevacizumab | Efficacy






Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Bevacizumab > Efficacy






Zhang JF, Okai B, Iovoli A, Goulenko V, Attwood K, Lim J, Hess RM, Abad AP, Prasad D, Fenstermaker RA.
Bevacizumab and gamma knife radiosurgery for first-recurrence glioblastoma.
J Neurooncol. 2024 Jan 4. doi: 10.1007/s11060-023-04524-y. PMID: 38175460. Observational study. ˍ




*Sferruzza G, Malcangi M, Bosco L, Finocchiaro G.
Reassessing the efficacy of bevacizumab in newly diagnosed glioblastoma: A systematic review and external pseudodata-based analysis.
Neurooncol Adv. 2024 Jan 22;6(1):vdad174. doi: 10.1093/noajnl/vdad174. PMID: 38390032. Review. ˍ




Habibi MA, Ghorbani M, Esmaeilian S, Tajvidi F, Nekutalaban P, Boskabadi AR, Alemi F, Zafari R, Mirjani MS, Eazi S, Minaee P.
Stereotactic radiosurgery versus combined stereotactic radiosurgery and bevacizumab for recurrent glioblastoma; a systematic review and meta-analysis of survival.
Neurosurg Rev. 2024 Jul 13;47(1):323. doi: 10.1007/s10143-024-02585-9. PMID: 39002028. Review; Meta-analysis˰ ˍ




Lee Y, Lee E, Roh TH, Kim SH.
Bevacizumab Alone Versus Bevacizumab Plus Irinotecan in Patients With Recurrent Glioblastoma: A Nationwide Population-Based Study.
J Korean Med Sci. 2024 Jul 29;39(34):e244. doi: 10.3346/jkms.2024.39.e244. PMID: 39228184. Observational study. ˍ




Habibi MA, Shad N, Mirjnani MS, Fasihi S, Sadeghi S, Karami S, Ahmadvand MH, Delbari P, Zare AH, Zare AH, Alavi SAN.
Is add-on Bevacizumab therapy to Temozolomide and radiotherapy associated with clinical utility for newly diagnosed Glioblastoma? A systematic review and meta-analysis.
Neurosurg Rev. 2024 Aug 20;47(1):445. doi: 10.1007/s10143-024-02667-8. PMID: 39162874. Review; Meta-analysis˰ ˍ




*Yang F, Wang L, Zhao W, Wang S, Li J, Sun A, Wang M, Wang Z, Chen Z, Heng X.
A Systematic Review and Meta-Analysis on the Effectiveness of Radiotherapy and Temozolomide Treatment With or Without Bevacizumab in Patients With Glioblastoma Multiforme.
Neurol India. 2024 Aug 31;72(4):700-707. doi: 10.4103/neurol-india.Neurol-India-D-23-00346. PMID: 39216020. Review; Meta-Analysis. ˍ